Results 131 to 140 of about 1,486 (188)

Global sociodemographic, clinical, and epidemiological profiling of patients with mycetoma: A systematic review. [PDF]

PLoS Negl Trop Dis
Salah ME, Salah ME, Fearon Scales ML, Habib K, Alhamwi F, Abdelwahab S, Ahmed Y, Khalid MM, Smith DJ, Fahal A.   +9 more
europepmc   +1 more source

Antiparasitic and Antifungal Activities of Cetyl-Maritima, a New <i>N</i>-Cetyl-Modified Maritima Derivative. [PDF]

Antibiotics (Basel)
Al Nasr IS, Ma J, Khan TA, Koko WS, Ben Abdelmalek I, Schobert R, van de Sande W, Biersack B.   +7 more
europepmc   +1 more source

Special Issue "Antifungal Drug Discovery: Progresses, Challenges, Opportunities". [PDF]

Int J Mol Sci
Biersack B.
europepmc   +1 more source

Using (1,3)‐β‐D‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis

Mycoses, 2023
Abstract Introduction (1,3)‐β‐D‐glucan is a panfungal biomarker secreted by many fungi, including Madurella mycetomatis, the main causative agent of eumycetoma. Previously we demonstrated that (1,3)‐β‐D‐glucan was present in serum of patients with eumycetoma.
Bertrand Nyuykonge, Emmanuel Edwar Siddig, Borna A Nyaoke   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Highly-stable Madurella mycetomatis laccase immobilized in silica-coated ZIF-8 nanocomposites for environmentally friendly cotton bleaching process.

Colloids and Surfaces B: Biointerfaces, 2021
In this study, a laccase from Madurella mycetomatis (MmLac) was produced heterologously in Pichia pastoris; the initial immobilization in a metal-organic framework (MOF) (MmLac/ZIF-8) was achieved using zinc nitrate and 2-methylimidazole.
A. Tülek, D. Yıldırım, Derya Aydın, Barış Binay   +3 more
semanticscholar   +1 more source

Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for In Vitro Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole against Madurella mycetomatis

Antimicrobial Agents and Chemotherapy, 2021
For many fungal infections, in vitro susceptibility testing is used to predict if an isolate is resistant or susceptible to the antifungal agent used to treat the infection.
Bertrand Nyuykonge, Kimberly Eadie, Ahmed Hassan Fahal   +2 more
exaly   +2 more sources

Madurella infection in an immunocompromised host

International Journal of Dermatology, 2000
A 77‐year‐old farmer, born and living in Sardinia, affected by acute myelogenous leukemia and undergoing chemotherapy treatment with cytosine arabinoside, presented at the Institute of Dermatology of Sassari in March 1998 with multiple subcutaneous lesions on the legs (Fig. 1) which had appeared 3 months previously.
SATTA, Rosanna Rita, Sanna S, Cottoni F.
openaire   +3 more sources

Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella

bioRxiv, 2022
Background Mycetoma is a neglected, chronic granulomatous infection of the subcutaneous tissue, most often caused by the fungal pathogen Madurella mycetomatis. Characteristic of the infection is the formation of grains. However, knowledge of the function
I. Abugessaisa, Mickey Konings, Ri-ichiroh Manabe, T. Kawashima, A. Hasegawa, Chitose Takahashi, M. Tagami, Y. Okazaki, W. Lim, A. Verbon, A. Fahal, T. Kasukawa, W. V. D. van de Sande   +12 more
semanticscholar   +1 more source